EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine

I Margineanu, T Butnaru, F Gafar, D Baiceanu, R Dragomir, I Semianiv, F Mihaltan, I Munteanu, B Mahler, L Todoriko, S Margineanu, O Akkerman und 2 weitere

The International Journal of Tuberculosis and Lung Disease · 2023

DOI: 10.5588/ijtld.22.0667 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2023. Verfasst von I Margineanu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University Medical Centrum Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Therapeutic drug monitoring (TDM) could improve TB treatment outcomes by avoiding drug toxicity or underdosing. In this study, we describe the patient burden in three TB centres in Romania and Ukraine with a TDM indication, as per the current guidelines, in order to estimate the feasibility of implementing TDM. METHODS: A retrospective multi-centre study was conducted at the Iasi Lung Hospital (Iasi, Romania), Bucharest Marius Nasta Institute (Bucharest, Romania) and Chernivtsi TB Centre (Chernivtsi, Ukraine) in adult hospitalised TB patients. RESULTS: A total of 927 participants were admitted, of whom 37.8% had at least one indication for TDM, the most frequent being slow response to TB treatment (202/345, 58.6%); 55.5% had at least one cavity present on chest X-ray. Patients with a TDM indication stayed in the hospital for a median of 67 days and took on average 2 months more to reach a successful TB outcome. CONCLUSION: TDM could be a valuable tool to improve management of selected TB patients. The decision on whether to perform TDM is often delayed by 2 months due to waiting for culture results after treatment initiation. A randomised control trial should be performed in order to define TDM’s precise role in TB therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TuberculosisAdultHumansDrug MonitoringRomaniaUkraineRetrospective Studies

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacology, University Medical Centrum Groningen, University of Groningen, Groningen, The Netherlands.
  • Prof Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
  • Unit of Pharmacotherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
  • Chernivtsi TB Expertise Centre, Bukovinian State Medical University, Chernivtsi, Ukraine.
  • Department of Computer and Data Sciences, Ion Ionescu de la Brad Iasi University of Life Sciences, Iasi, Romania.
  • Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, Tuberculosis Center Beatrixoord, University Medical Center Groningen, University of Groningen,…

Zitieren

APA

Margineanu, I., Butnaru, T., Gafar, F., Baiceanu, D., Dragomir, R., Semianiv, I., Mihaltan, F., Munteanu, I., Mahler, B., Todoriko, L., Margineanu, S., Akkerman, O., Stienstra, Y., & Alffenaar, J. C. (2023). TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.22.0667

Vancouver

Margineanu I, Butnaru T, Gafar F, Baiceanu D, Dragomir R, Semianiv I, et al. TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine. The International Journal of Tuberculosis and Lung Disease. 2023. doi:10.5588/ijtld.22.0667

BibTeX
@article{Margineanu2023,
  author = {Margineanu, I and Butnaru, T and Gafar, F and Baiceanu, D and Dragomir, R and Semianiv, I and Mihaltan, F and Munteanu, I and Mahler, B and Todoriko, L and Margineanu, S and Akkerman, O and Stienstra, Y and Alffenaar, J-W C},
  title = {TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2023},
  doi = {10.5588/ijtld.22.0667}
}
Kostenlos starten →